Journals A-Z
All Subjects
Free Journals
sciepub.com
American Journal of Pharmacological Sciences
ISSN (Print): 2327-6711 ISSN (Online): 2327-672X Website: https://www.sciepub.com/journal/ajps Editor-in-chief: Srinivas NAMMI
Open Access
Journal Browser
Go
Issue 2, Volume 11
Article Metrics
  • 2156
    Views
  • 2319
    Saves
  • 0
    Citations
  • 0
    Likes
Export Article
American Journal of Pharmacological Sciences. 2023, 11(2), 35-43
DOI: 10.12691/ajps-11-2-2
Open AccessReview Article

Clinical Research Related Documents and Data Management: An Update

Venkataramana Kandi1, and Sabitha Vadakedath1

1Prathima Institute of Medical Sciences, Karimnagar, India

Pub. Date: October 17, 2023
View Full Text Full Text PDF (291 KB) Full Text ePUB(216 KB)

Cite this paper:
Venkataramana Kandi and Sabitha Vadakedath. Clinical Research Related Documents and Data Management: An Update. American Journal of Pharmacological Sciences. 2023; 11(2):35-43. doi: 10.12691/ajps-11-2-2

Abstract

Clinical research is a way of doing research that is primarily aimed to solve a human health and/or ailment-related problem. However, clinical research is complex and involves factors that influence the accuracy of the study results. The clinical research-related documents and data management assumes increased significance. The data obtained from the clinical research is collected, stored, validated, distributed, analyzed, and managed according to standard recommendations as prescribed by the national and international regulatory agencies. The nature of the case record form, the data validation process, quality assurance during data collection, validation, database creation, pharmacovigilance, the role played by the regulatory authorities, and other aspects of clinical trial data management are discussed comprehensively in this review.

Keywords:
clinical research human health data management case record form regulatory agencies pharmacovigilance

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Seyhan, A.A. Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles. transl med commun 4, 18 (2019).
 
[2]  Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 May 12; 323(18): 1824-1836.
 
[3]  Park JJH, Mogg R, Smith GE, Nakimuli-Mpungu E, Jehan F, Rayner CR, Condo J, Decloedt EH, Nachega JB, Reis G, Mills EJ. How COVID-19 has fundamentally changed clinical research in global health. Lancet Glob Health. 2021 May; 9(5): e711-e720.
 
[4]  Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, Gras-Martin L, Fonts N. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep. 2021 Jan 13; 11(1): 883.
 
[5]  Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary. Washington (DC): National Academies Press (US); 2010. 3, Challenges in Clinical Research. Available from: .
 
[6]  Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters [published correction appears in Biostatistics. 2019 Apr 1; 20(2): 366]. Biostatistics. 2019; 20(2): 273-286.
 
[7]  Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, Jamerson B, McCullough C, Pierre C, Polis AB, Puckrein G, Regnante JM. Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Curr Probl Cardiol. 2019 May; 44(5): 148-172.
 
[8]  Queiroz VNF, Oliveira ADCM, Chaves RCF, Moura LAB, César DS, Takaoka F, Serpa Neto A. Methodological description of clinical research data collection through electronic medical records in a center participating in an international multicenter study. Einstein (Sao Paulo). 2019 Sep 23; 17(4): eAE4791.
 
[9]  Goodarzynejad H, Babamahmoodi A. Project Management of Randomized Clinical Trials: A Narrative Review. Iran Red Crescent Med J. 2015; 17(8): e11602. Published 2015 Aug 24.
 
[10]  Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT. Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development. JACC Heart Fail. 2019 Nov; 7(11): 913-921.
 
[11]  Wasserman RC. The patient record and the rise of the pediatric EHR. Curr Probl Pediatr Adolesc Health Care. 2021 Dec 9:101108.
 
[12]  Delacrétaz R, Fumeaux CJF, Stadelmann C, Rodriguez Trejo A, Destaillats A, Giannoni E. Intra-hospital transport of newborn infants dataset. Data Brief. 2021 Oct 29; 39: 107510.
 
[13]  Lee HA, Kung HH, Lee YJ, Chao JC, Udayasankaran JG, Fan HC, Ng KK, Chang YK, Kijsanayotin B, Marcelo AB, Hsu CY. Global Infectious Disease Surveillance and Case Tracking System for COVID-19: Development Study. JMIR Med Inform. 2020 Dec 22; 8(12): e20567.
 
[14]  Ohmann C, Banzi R, Canham S, Battaglia S, Matei M, Ariyo C, Becnel L, Bierer B, Bowers S, Clivio L, Dias M, Druml C, Faure H, Fenner M, Galvez J, Ghersi D, Gluud C, Groves T, Houston P, Karam G, Kalra D, Knowles RL, Krleža-Jerić K, Kubiak C, Kuchinke W, Kush R, Lukkarinen A, Marques PS, Newbigging A, O'Callaghan J, Ravaud P, Schlünder I, Shanahan D, Sitter H, Spalding D, Tudur-Smith C, van Reusel P, van Veen EB, Visser GR, Wilson J, Demotes-Mainard J. Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open. 2017 Dec 14; 7(12): e018647.
 
[15]  International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). . Accessed January 9th 2022.
 
[16]  The Role of ICH and How to Meet Quality Guidelines in API Manufacturing. . Accessed January 9th 2022.
 
[17]  Efficacy Guidelines. . Accessed 9th January 2022.
 
[18]  ICH HARMONISED TRIPARTITE GUIDELINE GENERAL CONSIDERATIONS FOR CLINICAL TRIALS E8. .
 
[19]  Rebecca Sheets and Ivana Knezevic. International regulatory convergence. In: Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines. Ed. Rebecca Sheets. Elsevier 2018 p 29-40. 10.1016/B798-0-12-809290-3.00003-1 .
 
[20]  Michael O'Kelly. Regulatory guidance-a quick tour. In: Clinical Trials with Missing Data: A Guide for Practitioners. Ed. Michael O'Kelly, Bohdana Ratitch. 1st Edition 2014John Wiley & Sons, Ltd. .
 
[21]  Wright P, Haybittle J. Design of forms for clinical trials (3). Br Med J. 1979 Sep 15; 2(6191): 650-1.
 
[22]  Bellary S, Krishnankutty B, and Latha MS. Basics of case report form designing in clinical research. Perspect Clin Res. 2014; 5(4): 159–166 10.4103/2229-3485.140555.
 
[23]  Abu Saleh Mohammad Mosa, Illhoi Yoo, Jerry C. Parker. Online Electronic Data Capture and Research Data Repository System for Clinical and Translational Research. Mo Med. 2015 Jan-Feb; 112(1): 46–52.
 
[24]  Eun-Young Kim. Development and Application of Direct Data Capture for Monitoring Medication Compliance in Clinical Trials. Healthc Inform Res. 2017 Oct; 23(4): 249–254.
 
[25]  Collignon O, Koenig F, Koch A, et al. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency. Trials. 2018; 19(1): 642.
 
[26]  Simon M, Habeck M, Büttner D, et al. Approval procedures for clinical trials in the field of radiation oncology. Strahlenther Onkol. 2015 Dec; 191(12): 909-20.
 
[27]  Mtove G, Kimani J, Kisinza W, et al. Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings. Trials. 2018 Mar 22; 19(1): 190.
 
[28]  Binny Krishnankutty, Shantala Bellary, Naveen B.R. Kumar, and Latha S. Moodahadu. Data management in clinical research: An overview. Indian J Pharmacol. 2012 Mar-Apr; 44(2): 168–172.
 
[29]  Gazali, Sandeep Kaur, Inderbir Singh. Artificial intelligence based clinical data management systems: A review. Informatics in Medicine Unlocked. 2017; 9: 219-229.
 
[30]  Diane Whitham, 1 Julie Turzanski, 1 Lucy Bradshaw, et al. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study. Trials. 2018; 19: 557.
 
[31]  Deven Babre. Medical Coding in Clinical Trials. Perspect Clin Res. 2010 Jan-Mar; 1(1): 29–32.
 
[32]  Michael C Wendl, Scott Smith, Craig S Pohl, et al. Design and implementation of a generalized laboratory data model. BMC Bioinformatics. 2007; 8: 362.
 
[33]  Colmsee, C., Flemming, S., Klapperstück, M. et al. A case study for efficient management of high throughput primary lab data. BMC Res Notes 4, 413 (2011).
 
[34]  Sanvidhan G Suke, Prabhat Kosta, and Harsh Negi. Role of Pharmacovigilance in India: An overview. Online J Public Health Inform. 2015; 7(2): e223.
 
[35]  Bercu, J., Berlam, S.C., Berridge, J. et al. Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities J Pharm Innov (2019) 14: 76.
 
[36]  Frank J.Schwebela, Mary E.Larimer. Using text message reminders in health care services: A narrative literature review. Internet Interventions 2018; 13: 82-104.
 
[37]  Yang E, O'Donovan C, Phillips J, Atkinson L, Ghosh K, Agrafiotis DK. Quantifying and visualizing site performance in clinical trials. Contemp Clin Trials Commun. 2018 Jan 31; 9: 108-114.
 
[38]  Michael J. Denney, Dustin M. Long, Matthew G. Armistead, BS, Jamie L. Anderson, and Baqiyyah N. Conway. Validating the Extract, Transform, Load Process Used to Populate a Large Clinical Research Database. Int J Med Inform. 2016 Oct; 94: 271–274.
 
[39]  Mathews, S.C., McShea, M.J., Hanley, C.L. et al. Digital health: a path to validation. npj Digit. Med. 2, 38 (2019).
 
[40]  Tabi K, Randhawa AS, Choi F, Mithani Z, Albers F, Schnieder M, Nikoo M, Vigo D, Jang K, Demlova R, Krausz M. Mobile Apps for Medication Management: Review and Analysis JMIR Mhealth Uhealth 2019;7(9):e13608 .
 
[41]  Perrin C, Bediang G, Randriambelonoro M and Geissbuhler A (2019) Learning From eHealth Implementations Through “Implementomics”: A Multidimensional Annotation Model Applied to eHealth Projects of the RAFT Network. Front. Public Health 7:188.
 
[42]  Scott W. Roberts, Nina S. Cauchon, Minhui Ma, Jeroen Bezemer, Xichen Zhang, Eric Weilage, Omari Anson. Control Strategy Expectations in Early Clinical Phase Synthetic Oncology Programs: Two Global Regulatory Case Studies. Org. Process Res. Dev. 2020, 24, 1, 96-100.
 
[43]  Ching-HengLin, Nai-YuanWu, Der-MingLiou. A multi-technique approach to bridge electronic case report form design and data standard adoption. Journal of Biomedical Informatics. 2015; 53: 49-57.
 
[44]  David A. Rorie, Robert W. V. Flynn, Kerr Grieve, Alexander Doney, Isla Mackenzie, Thomas M. MacDonald, and Amy Rogers. Electronic case report forms and electronic data capture within clinical trials and pharmacoepidemiology. Br J Clin Pharmacol. 2017 Sep; 83(9): 1880–1895.
 
[45]  Balasubramanian BA, Heurtin-Roberts S, Krasny S, et al. Factors Related to Implementation and Reach of a Pragmatic Multisite Trial: The My Own Health Report (MOHR) Study. J Am Board Fam Med. 2017 May-Jun; 30(3): 337-349.
 
[46]  Benchoufi, M., Ravaud, P. Blockchain technology for improving clinical research quality. Trials 18, 335 (2017).
 
[47]  Wong DR, Bhattacharya S, Butte AJ. Prototype of running clinical trials in an untrustworthy environment using blockchain. Nat Commun. 2019; 10(1):917. Published 2019 Feb 22.
 
Manuscript template